Neurobiology of Aging
Volume 30, Issue 7 , Pages 1026-1036 , July 2009

Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease

  • Joseph L. Price

      Affiliations

    • Department of Anatomy and Neurobiology, Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, United States
    • ,
  • Daniel W. McKeel Jr.

      Affiliations

    • Department of Pathology and Immunology, Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, United States
    • Retired.
    • ,
  • Virginia D. Buckles

      Affiliations

    • Department of Neurology, Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, United States
    • ,
  • Catherine M. Roe

      Affiliations

    • Department of Neurology, Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, United States
    • ,
  • Chengjie Xiong

      Affiliations

    • Division of Biostatistics, Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, United States
    • ,
  • Michael Grundman

      Affiliations

    • Elan Pharmaceuticals, San Diego, CA, United States
    • ,
  • Lawrence A. Hansen

      Affiliations

    • Department of Neuroscience, University of California – San Diego, La Jolla, CA, United States
    • ,
  • Ronald C. Petersen

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN, United States
    • ,
  • Joseph E. Parisi

      Affiliations

    • Department of Anatomic Pathology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States
    • ,
  • Dennis W. Dickson

      Affiliations

    • Neuro-Oncology Program and Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, United States
    • ,
  • Charles D. Smith

      Affiliations

    • Department of Neurology, University of Kentucky, Lexington, KY, United States
    • ,
  • Daron G. Davis

      Affiliations

    • Pathology Department, Central Baptist Hospital, Lexington, KY, United States
    • ,
  • Frederick A. Schmitt

      Affiliations

    • Sanders-Brown Center on Aging, Alzheimer's Disease Center, University of Kentucky, Lexington, KY, United States
    • ,
  • William R. Markesbery

      Affiliations

    • Sanders-Brown Center on Aging, Alzheimer's Disease Center, University of Kentucky, Lexington, KY, United States
    • ,
  • Jeffrey Kaye

      Affiliations

    • Layton Aging & Alzheimer Disease Center, Oregon Health Sciences University, Portland, OR, United States
    • ,
  • Roger Kurlan

      Affiliations

    • Department of Neurology, University of Rochester School of Medicine, Rochester, NY, United States
    • ,
  • Christine Hulette

      Affiliations

    • Department of Pathology and Division of Neurology, Duke University Medical Center, Durham, NC, United States
    • ,
  • Brenda F. Kurland

      Affiliations

    • Clinical Statistics, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
    • ,
  • Roger Higdon

      Affiliations

    • The BIATECH Institute, Seattle, WA, United States
    • ,
  • Walter Kukull

      Affiliations

    • Department of Epidemiology, University of Washington, Seattle, WA, United States
    • ,
  • John C. Morris

      Affiliations

    • Department of Pathology and Immunology, Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, United States
    • Department of Neurology, Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, United States
    • Department of Physical Therapy, Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, United States
    • Corresponding Author InformationCorresponding author at: 4488 Forest Park Avenue, Suite 130, St. Louis, MO 63108, United States. Tel.: +1 314 286 2881; fax: +1 314 286 2763.

Received 13 February 2009 ,Revised 3 April 2009 ,Accepted 6 April 2009.

References 

  1. Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I, et al. Interlaboratory comparison of assessments of Alzheimer disease-related lestions: a study of the BrainNet Europe Consortium. J. Neuropathol. Exp. Neurol. 2006;65:740–757
  2. Armitage SG. An analysis of certain psychological tests used in the evaluation of brain injury. Psych. Mono. 1946;60:1–48
  3. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 1992;42:1681–1688
  4. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol. 2004;61:378–384
  5. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006;66:1837–1844
  6. Berg L, McKeel DW, Miller JP, Storandt M, Rubin EH, Morris JC, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch. Neurol. 1998;55:326–335
  7. Berlau DJ, Kahle-Wrobleski K, Head E, Goodus M, Kim R, Kawas C. Dissociation of neuropathological findings and cognition; Case report of an Apolipoprotein E å2/å2 Genotype. Arch. Neurol. 2007;64:1193–1196
  8. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259
  9. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging. 1997;18:351–357
  10. Castellani RJ, Lee HG, Zhu X, Perry G, Smith MA. Alzheimer disease pathology as a host response. J. Neuropathol. Exp. Neurol. 2008;67:523–531
  11. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 1988;38:1682–1687
  12. den Dunnen WFA, Brouwer WH, Bijlard E, Kamphuis J, Linschoten KV, Essens-Meijer E, et al. No disease in the brain of a 115 year old woman. Neurobiol. Aging. 2008;29:1127–1132
  13. Dickson D, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 1992;13:179–189
  14. Dickson DW. Mismatch between plaques and tangles in staging Alzheimer pathology. Neurobiol. Aging. 1995;16:283–284
  15. Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol. 2008;115:437–444
  16. Driscoll I, Resnick SM, Troncoso JC, An Y, O’Brien R, Zonderman AB. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann. Neurol. 2006;60:688–695
  17. Elias MF, Beiser A, Wolf PA, Au R, White RF, D’Agostino RB. The preclinical phase of Alzheimer disease. A 22-year prospective study of the Famingham cohort. Arch. Neurol. 2000;57:808–813
  18. Ertekin-Taner N, Younkin LH, Yager DM, Parfitt F, Baker MC, Asthana S, et al. Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. Neurology. 2008;70:596–606
  19. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Cerebrospinal fluid tau/ß-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 2007;64:343–349
  20. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinicians. J. Psychiatr. Res. 1975;12:189–198
  21. Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL. Brain volume decline in aging: evidence for a relationship between socioeconomic status, preclinical Alzheimer's disease, and reserve. Arch. Neurol. 2008;65:113–120
  22. Galvin JE, Powlishta KK, Wilkins K, McKeel D, Xiong C, Grant E, et al. Predictors of preclinical Alzheimer's disease and dementia: a clinicopathologic study. Arch. Neurol. 2005;62:758–765
  23. Geddes JW, Tekirian TL, Soultanian NS, Ashford JW, Davis DG, Markesbery WR. Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiol. Aging. 1997;18:S99–S105
  24. Goldman WP, Price JL, Storandt M, Grant EA, McKeel DW, Rubin EH, et al. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology. 2001;56:361–367
  25. Gomez-Isla T, Price JL, McKeel DW, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 1996;16:4491–4500
  26. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. second ed.. Philadelphia: Lea & Febiger; 1983;
  27. Haroutunian V, Perl DP, Purohit DP, Marin D, Khalid K, Lantz M, et al. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch. Neurol. 1998;55:1185–1191
  28. Haroutunian V, Purohit DP, Perl DP, Marin D, Khan K, Lantz M, et al. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch. Neurol. 1999;56:713–718
  29. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population. Arch. Neurol. 2003;60:1119–1122
  30. Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre NJ. Neuropathological and neuropsychological changes in “normal” aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J. Neuropathol. Exp. Neurol. 1998;57:1168–1174
  31. Hung LW, Ciccotosto G, Giannakis E, Tew DJ, Perez K, Masters CL, et al. Amyloid-β peptide (Aβ) neurotoxicity is modulated by the rate of peptide aggregation: Aβ dimers and trimers correlate with neurotoxicity. J. Neurosci. 2008;28:11950–11958
  32. Iacono D, O’Brien R, Resnick SM, Zonderman AB, Pletnikova O, Rudow G, et al. Neuronal hypertropy in asymptomatic Alzheimer disease. J. Neuropathol. Exp. Neurol. 2008;67:578–589
  33. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 1988;23:138–144
  34. Kawas CH, Corrada MM, Brookmeyer R, Morrison A, Resnick SM, Zonderman AB, et al. Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology. 2003;60:1089–1093
  35. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch. Neurol. 1985;42:1097–1105
  36. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004;55:306–319
  37. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, et al. Neuropathology of cognitively normal elderly. J. Neuropathol. Exp. Neurol. 2003;62:1087–1095
  38. Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW, et al. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology. 2001;56:127–129
  39. McKeel DW, Price JL, Miller JP, Grant EA, Xiong C, Berg L, et al. Neuropathologic criteria for diagnosing Alzheimer Disease in persons with pure dementia of Alzheimer type. J. Neuropathol. Exp. Neurol. 2004;63:1028–1037
  40. Mintun MA, LaRossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, et al. [11C] PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 2006;67:446–452
  41. Mirra SS, Gearing M, McKeel DW, Crain BJ, Hughes JP, van Belle G, et al. Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). J. Neuropathol. Exp. Neurol. 1994;53:303–315
  42. Mirra SS, Heyman A, McKeel DW, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479–486
  43. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–2414
  44. Morris JC, Storandt M, McKeel DW, Rubin EH, Price JL, Grant EA, et al. Cerebral amyloid deposition and diffuse plaques in “normal” aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 1996;46:707–719
  45. National Institute on Aging, Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging. 1997;18:S1–S2
  46. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging. 1991;12:295–312
  47. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch. Neurol. 2001;58:1395–1402
  48. Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease. Ann. Neurol. 1999;45:358–368
  49. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 2007;13:1359–1362
  50. Riudavets MA, Iacono D, Resnick SM, O’Brien R, Zonderman AB, Martin LJ, et al. Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol. Aging. 2007;28:1484–1492
  51. Saxton J, Lopez OL, Ratcliff G, Dulberg C, Fried LP, Carlson MC, et al. Preclinical Alzheimer disease; neuropsychological test performance 1.5 to 8 years prior to onset. Neurology. 2004;63:2341–2347
  52. Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. Preclinical AD revisited. Neuropathology of cognitively normal older adults. Neurology. 2000;55:370–376
  53. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008;837–842
  54. Stern Y. Cognitive reserve and Alzheimer disease. Alz. Dis. Assoc. Disord. 2006;20:112–117
  55. Tierney MC, Yao C, Kiss A, McDowell I. Neurospsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology. 2005;64:1853–1859
  56. Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J. Neurol. Sci. 1968;7:331–356
  57. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J. Neurol. Sci. 1970;11:205–242
  58. Troncoso JC, Cataldo M, Nixon RA, Barnett JL, Lee MK, Checler F, et al. Neuropathology of preclinical and clinical late-onset Alzheimer's disease. Ann. Neurol. 1998;43:673–676
  59. Troncoso JC, Martin LJ, Dal Forno G, Kawas CH. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol. Aging. 1996;17:365–371
  60. Wechsler D. Manual: Wechsler Memory Scale-Revised. San Antonio, TX: Psychological Corporation; 1987;
  61. Wechsler D. Administration and Scoring Manual: Wechsler Adult Intelligence Scale. third ed. San Antonio, TX: Harcourt Brace; 1997;
  62. West MJ, Kawas CH, Stewart WF, Rudow GL, Troncoso JC. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol. Aging. 2004;25:1205–1212

PII: S0197-4580(09)00117-1

doi: 10.1016/j.neurobiolaging.2009.04.002

Neurobiology of Aging
Volume 30, Issue 7 , Pages 1026-1036 , July 2009

Article Tools

* Image Usage & Resolution